Feasibility and Dose Discovery Analysis of Zoledronic Acid With Concurrent Chemotherapy in the Treatment of Newly Diagnosed Metastatic Osteosarcoma.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2013
At a glance
- Drugs Zoledronic acid (Primary) ; Cisplatin; Dexrazoxane; Doxorubicin; Etoposide; Ifosfamide; Methotrexate
- Indications Osteosarcoma
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 17 Apr 2012 Actual end date (1 Apr 2012 ) added as reported by ClinicalTrials.gov.
- 17 Apr 2012 Status changed from suspended to completed as reported by ClinicalTrials.gov